Nifty

:

22147.90

Sensex

:

72943.68

-124.60 (-0.56%)
-456.10 (-0.62%)

Login

Nifty
Sensex

:
:

22147.90
72943.68

-124.60 (-0.56%)
-456.10 (-0.62%)

Balaxi Pharmaceuticals Ltd.

Finance - Investment

Rating :

40/99

BSE: Not Listed | NSE: BALAXI

Watchlist

NSE BSE

578.35

16-Apr-2024

Open
High
Low
Previous Close

569.95
587.25
569.95
569.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11612
66.92
686.30
399.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

638.59
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

629.18
N/A
3.18

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

94.44
89.96
13.30

EBITDA CAGR (%)

10 Years
5 Years
3 Years

65.41
105.67
6.11

PAT CAGR (%)

10 Years
5 Years
3 Years

64.77
87.75
6.41

P:E (Median)

8 Years
5 Years
3 Years

-
-
10.75

P:BV (Average)

8 Years
5 Years
3 Years

-
-
4.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
10.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 12.70 23.07 -44.95% 16.55 28.26 -41.44% 25.04 26.45 -5.33% 30.35 20.65 46.97%
Expenses 12.42 19.50 -36.31% 15.64 24.74 -36.78% 21.27 22.22 -4.28% 24.95 16.74 49.04%
EBITDA 0.28 3.56 -92.13% 0.91 3.53 -74.22% 3.77 4.24 -11.08% 5.40 3.91 38.11%
EBIDTM 2.20% 15.45% 5.51% 12.47% 15.06% 16.02% 17.80% 18.91%
Other Income 1.03 1.35 -23.70% 1.15 2.50 -54.00% 0.13 2.57 -94.94% 0.18 1.07 -83.18%
Interest 0.41 0.01 4,000.00% 0.36 0.02 1,700.00% 0.26 0.20 30.00% 0.23 0.02 1,050.00%
Depreciation 0.13 0.08 62.50% 0.13 0.08 62.50% 0.13 0.08 62.50% 0.27 0.08 237.50%
PBT 0.77 4.81 -83.99% 1.57 5.92 -73.48% 3.51 6.53 -46.25% 5.09 4.88 4.30%
Tax 0.28 1.28 -78.12% 0.39 1.95 -80.00% 0.95 1.20 -20.83% 1.15 1.35 -14.81%
PAT 0.49 3.53 -86.12% 1.18 3.98 -70.35% 2.55 5.34 -52.25% 3.94 3.53 11.61%
PATM 3.84% 15.31% 7.14% 14.07% 10.20% 20.17% 12.99% 17.08%
EPS 0.45 3.24 -86.11% 1.08 3.65 -70.41% 2.34 4.90 -52.24% 3.62 3.24 11.73%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 60.79 86.58 -29.79% 54.72 86.39 -36.66% 65.95 82.78 -20.33% 80.68 89.10 -9.45%
Expenses 47.13 71.29 -33.89% 43.96 71.63 -38.63% 57.11 69.04 -17.28% 67.94 77.87 -12.75%
EBITDA 13.66 15.29 -10.66% 10.76 14.75 -27.05% 8.84 13.75 -35.71% 12.74 11.23 13.45%
EBIDTM 22.47% 17.66% 19.67% 17.08% 13.40% 16.61% 15.79% 12.60%
Other Income -0.13 -4.56 - 0.28 4.14 -93.24% -1.01 3.28 - -0.22 4.07 -
Interest 0.42 0.01 4,100.00% 0.37 0.02 1,750.00% 0.29 0.20 45.00% 0.27 0.10 170.00%
Depreciation 0.48 0.19 152.63% 0.66 0.19 247.37% 0.29 0.19 52.63% 1.19 0.17 600.00%
PBT 14.27 10.53 35.52% 15.66 18.68 -16.17% -39.41 16.65 - 11.07 15.02 -26.30%
Tax 0.68 2.30 -70.43% 1.23 3.19 -61.44% 1.93 2.50 -22.80% 2.97 2.31 28.57%
PAT 13.59 8.23 65.13% 14.43 15.49 -6.84% -41.34 14.15 - 8.10 12.71 -36.27%
PATM 22.36% 9.50% 26.37% 17.93% -62.68% 17.09% 10.04% 14.27%
EPS 13.29 8.21 61.88% 14.10 15.49 -8.97% -40.41 14.15 - 7.96 12.71 -37.37%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 84.64 108.14 101.29 86.87 45.63 13.60 0.00 0.00 0.05 0.12 0.14 Net Sales Growth -14.01% 6.76% 16.60% 90.38% 235.51% 0 0 -100% -58.33% -14.29% Cost Of Goods Sold 65.97 82.10 76.92 63.33 32.83 10.24 0.00 0.00 0.00 0.00 0.00 Gross Profit 18.67 26.04 24.37 23.54 12.81 3.36 0.00 0.00 0.05 0.12 0.14 GP Margin 22.06% 24.08% 24.06% 27.10% 28.07% 24.71% 0 0 100% 100% 100% Total Expenditure 74.28 91.27 83.99 67.85 36.99 12.04 0.77 0.13 0.12 0.08 0.03 Power & Fuel Cost - 0.04 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.04% 0.02% 0% 0% 0% 0 0 0% 0% 0% Employee Cost - 4.04 2.90 1.95 1.75 0.90 0.15 0.07 0.06 0.02 0.01 % Of Sales - 3.74% 2.86% 2.24% 3.84% 6.62% 0 0 120.0% 16.67% 7.14% Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0 0 0% 0% 0% General & Admin Exp. - 4.54 3.51 2.11 2.29 0.61 0.59 0.06 0.06 0.04 0.02 % Of Sales - 4.20% 3.47% 2.43% 5.02% 4.49% 0 0 120.0% 33.33% 14.29% Selling & Distn. Exp. - 0.21 0.40 0.07 0.10 0.21 0.03 0.00 0.00 0.01 0.00 % Of Sales - 0.19% 0.39% 0.08% 0.22% 1.54% 0 0 0% 8.33% 0% Miscellaneous Exp. - 0.35 0.24 0.39 0.02 0.08 0.00 0.00 0.00 0.01 0.00 % Of Sales - 0.32% 0.24% 0.45% 0.04% 0.59% 0 0 0% 8.33% 0% EBITDA 10.36 16.87 17.30 19.02 8.64 1.56 -0.77 -0.13 -0.07 0.04 0.11 EBITDA Margin 12.24% 15.60% 17.08% 21.89% 18.93% 11.47% 0 0 -140.0% 33.33% 78.57% Other Income 2.49 6.60 2.75 1.81 0.59 0.89 0.00 0.00 0.00 0.12 0.05 Interest 1.26 0.51 0.10 0.15 0.05 0.00 0.00 0.04 0.05 0.01 0.01 Depreciation 0.66 0.52 0.25 0.09 0.01 0.00 0.00 0.00 0.00 0.00 0.00 PBT 10.94 22.45 19.70 20.60 9.19 2.44 -0.77 -0.17 -0.12 0.15 0.15 Tax 2.77 6.23 5.03 5.46 2.69 0.47 0.00 0.00 -0.04 0.04 0.04 Tax Rate 25.32% 27.75% 25.53% 26.50% 29.27% 19.26% 0.00% 0.00% 33.33% 26.67% 26.67% PAT 8.16 16.22 14.67 15.13 6.50 1.97 -0.77 -0.17 -0.08 0.10 0.11 PAT before Minority Interest 8.16 16.22 14.67 15.13 6.50 1.97 -0.77 -0.17 -0.08 0.10 0.11 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.64% 15.00% 14.48% 17.42% 14.25% 14.49% 0 0 -160.0% 83.33% 78.57% PAT Growth -50.18% 10.57% -3.04% 132.77% 229.95% - - - - -9.09% EPS 7.49 14.88 13.46 13.88 5.96 1.81 -0.71 -0.16 -0.07 0.09 0.10

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 262.14 336.43 279.39 231.33 45.63 13.60 Net Sales Growth -23.98% 20.42% 20.78% 406.97% 235.51% Cost Of Goods Sold 150.87 202.42 195.60 172.15 32.83 10.24 Gross Profit 111.27 134.02 83.79 59.19 12.81 3.36 GP Margin 42.45% 39.84% 29.99% 25.59% 28.07% 24.71% Total Expenditure 216.14 279.02 228.56 188.66 37.38 12.04 Power & Fuel Cost - 0.28 0.35 0.00 0.00 0.00 % Of Sales - 0.08% 0.13% 0% 0% 0% Employee Cost - 28.95 12.47 8.47 2.10 0.90 % Of Sales - 8.61% 4.46% 3.66% 4.60% 6.62% Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% General & Admin Exp. - 35.00 14.98 5.28 2.34 0.61 % Of Sales - 10.40% 5.36% 2.28% 5.13% 4.49% Selling & Distn. Exp. - 0.84 1.02 0.10 0.10 0.21 % Of Sales - 0.25% 0.37% 0.04% 0.22% 1.54% Miscellaneous Exp. - 11.52 4.16 2.65 0.02 0.08 % Of Sales - 3.42% 1.49% 1.15% 0.04% 0.59% EBITDA 46.00 57.41 50.83 42.67 8.25 1.56 EBITDA Margin 17.55% 17.06% 18.19% 18.45% 18.08% 11.47% Other Income -1.08 2.64 4.97 2.23 0.59 0.89 Interest 1.35 1.38 0.76 0.28 0.05 0.00 Depreciation 2.62 1.75 0.51 0.30 0.01 0.00 PBT 1.59 56.92 54.52 44.33 8.79 2.44 Tax 6.81 10.96 6.86 6.19 2.69 0.47 Tax Rate 428.30% 19.26% 12.58% 13.96% 30.60% 19.26% PAT -5.22 45.96 47.66 38.14 6.10 1.97 PAT before Minority Interest -5.22 45.96 47.66 38.14 6.10 1.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -1.99% 13.66% 17.06% 16.49% 13.37% 14.49% PAT Growth -110.32% -3.57% 24.96% 525.25% 209.64% EPS -4.79 42.17 43.72 34.99 5.60 1.81

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 92.11 57.91 43.25 28.11 3.52 1.55 2.32 3.15 3.22 0.78 Share Capital 10.18 10.00 10.00 10.00 3.04 3.04 3.04 3.04 3.04 0.70 Total Reserves 71.63 47.91 33.25 18.11 0.48 -1.49 -0.72 0.11 0.18 0.08 Non-Current Liabilities 2.79 0.04 0.01 0.00 0.00 0.00 0.00 -0.04 0.00 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 34.83 23.96 25.67 9.79 2.59 0.13 0.05 0.42 0.46 0.42 Trade Payables 17.26 15.75 16.64 6.91 2.08 0.09 0.00 0.00 0.13 0.00 Other Current Liabilities 2.31 1.54 0.08 0.46 0.04 0.03 0.03 0.03 0.03 0.02 Short Term Borrowings 10.75 1.93 3.51 0.00 0.00 0.00 0.00 0.20 0.00 0.18 Short Term Provisions 4.51 4.75 5.44 2.41 0.47 0.01 0.01 0.18 0.30 0.22 Total Liabilities 129.73 81.91 68.93 37.90 6.11 1.68 2.37 3.53 3.68 1.20 Net Block 7.89 2.20 0.69 0.19 0.01 0.01 0.00 0.00 0.00 0.00 Gross Block 8.75 2.54 0.78 0.19 0.01 0.01 0.00 0.01 0.01 0.01 Accumulated Depreciation 0.85 0.34 0.09 0.00 0.00 0.00 0.00 0.01 0.01 0.01 Non Current Assets 30.70 27.84 20.25 1.21 0.33 0.04 0.03 3.28 3.42 0.18 Capital Work in Progress 2.83 0.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 19.54 19.61 19.54 0.10 0.00 0.00 0.00 3.27 3.42 0.18 Long Term Loans & Adv. 0.04 0.59 0.02 0.92 0.32 0.03 0.03 0.00 0.00 0.00 Other Non Current Assets 0.40 4.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 99.02 54.08 48.67 36.70 5.78 1.65 2.34 0.26 0.26 1.03 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 Inventories 1.49 0.00 0.02 0.83 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 78.29 52.11 48.13 31.22 5.47 0.00 0.00 0.00 0.01 0.29 Cash & Bank 17.88 0.84 0.48 3.57 0.13 1.65 2.34 0.01 0.02 0.55 Other Current Assets 1.36 0.75 0.00 0.00 0.17 0.00 0.00 0.23 0.23 0.18 Short Term Loans & Adv. 0.62 0.37 0.05 1.08 0.17 0.00 0.00 0.20 0.20 0.13 Net Current Assets 64.19 30.11 23.00 26.91 3.19 1.51 2.29 -0.16 -0.19 0.60 Total Assets 129.72 81.92 68.92 37.91 6.11 1.69 2.37 3.54 3.68 1.21

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 182.88 113.16 64.98 27.75 3.52 Share Capital 10.18 10.00 10.00 10.00 3.04 Total Reserves 162.40 103.16 54.98 17.75 0.48 Non-Current Liabilities 3.66 0.04 0.01 0.00 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.87 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 Current Liabilities 53.13 63.27 34.69 8.22 2.59 Trade Payables 34.52 49.11 24.88 4.85 2.08 Other Current Liabilities 2.81 3.26 0.14 0.96 0.04 Short Term Borrowings 10.75 3.64 3.66 0.00 0.00 Short Term Provisions 5.06 7.25 6.01 2.42 0.47 Total Liabilities 239.67 176.47 99.68 35.97 6.11 Net Block 41.41 28.76 2.45 0.19 0.01 Gross Block 43.76 29.51 2.75 0.19 0.01 Accumulated Depreciation 2.35 0.76 0.30 0.00 0.00 Non Current Assets 46.16 35.47 5.91 1.11 0.33 Capital Work in Progress 2.83 0.57 0.00 0.00 0.00 Non Current Investment 0.00 0.00 3.42 0.00 0.00 Long Term Loans & Adv. 1.52 1.27 0.05 0.92 0.32 Other Non Current Assets 0.40 4.87 0.00 0.00 0.00 Current Assets 193.51 141.00 93.77 34.86 5.78 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 105.02 98.70 13.62 0.83 0.00 Sundry Debtors 52.28 27.56 76.76 29.71 5.47 Cash & Bank 28.22 7.19 1.67 4.00 0.13 Other Current Assets 7.99 3.90 0.77 0.00 0.17 Short Term Loans & Adv. 3.47 3.65 0.95 0.31 0.17 Net Current Assets 140.38 77.74 59.08 26.64 3.19 Total Assets 239.67 176.47 99.68 35.97 6.11

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -7.07 8.89 13.46 -14.37 -1.51 -0.68 -0.13 -0.03 0.21 -0.24 PBT 22.45 19.70 20.60 9.19 2.44 -0.77 -0.17 -0.12 0.15 0.15 Adjustment 0.97 0.31 0.10 0.01 0.00 0.00 0.04 0.00 -0.12 -0.05 Changes in Working Capital -25.08 -5.44 -4.80 -22.82 -3.94 0.09 0.00 0.08 0.25 -0.31 Cash after chg. in Working capital -1.66 14.57 15.90 -13.63 -1.50 -0.68 -0.13 -0.03 0.28 -0.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.41 -5.69 -2.44 -0.74 -0.01 0.00 0.00 0.00 -0.07 -0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2.29 -6.87 -20.03 -0.28 -0.01 -0.01 2.67 0.13 -3.11 0.33 Net Fixed Assets -8.47 -2.33 -0.59 -0.18 0.00 -0.01 0.01 0.00 0.00 0.00 Net Investments 0.07 -0.07 -19.44 -0.10 0.00 0.00 3.28 0.14 -3.23 0.28 Others 6.11 -4.47 0.00 0.00 -0.01 0.00 -0.62 -0.01 0.12 0.05 Cash from Financing Activity 26.39 -1.64 3.49 18.10 0.00 0.00 -0.24 -0.11 2.38 -0.07 Net Cash Inflow / Outflow 17.03 0.38 -3.08 3.44 -1.51 -0.69 2.30 -0.02 -0.52 0.02 Opening Cash & Equivalents 0.84 0.47 3.55 0.10 1.62 2.30 0.01 0.02 0.55 0.53 Closing Cash & Equivalent 17.87 0.84 0.47 3.55 0.10 1.62 2.30 0.01 0.02 0.55

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 6.08 34.14 0.00 -14.04 -1.51 PBT 56.92 54.52 44.33 8.79 2.44 Adjustment 8.03 1.18 -0.59 0.03 0.00 Changes in Working Capital -46.79 -15.97 -41.14 -22.12 -3.94 Cash after chg. in Working capital 18.17 39.74 2.60 -13.29 -1.50 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -12.09 -5.59 -2.59 -0.74 -0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -10.57 -28.45 -5.97 -0.18 -0.01 Net Fixed Assets -8.47 -2.33 -0.59 -0.18 Net Investments 0.07 -0.07 -19.44 -0.10 Others -2.17 -26.05 14.06 0.10 Cash from Financing Activity 25.51 -0.16 3.65 18.10 0.00 Net Cash Inflow / Outflow 21.02 5.53 -2.32 3.88 -1.51 Opening Cash & Equivalents 7.19 1.66 3.98 0.10 1.62 Closing Cash & Equivalent 28.21 7.19 1.66 3.98 0.10

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 80.35 57.91 43.25 28.11 11.58 5.11 7.65 10.36 10.61 11.14 ROA 15.33% 19.45% 28.33% 29.52% 50.44% -37.96% -5.90% -2.23% 4.19% 8.97% ROE 23.22% 29.00% 42.42% 41.07% 77.47% -39.69% -6.37% -2.52% 5.11% 14.30% ROCE 28.22% 37.14% 55.42% 58.38% 96.22% -39.69% -4.69% -2.11% 7.68% 18.55% Fixed Asset Turnover 19.16 61.00 179.45 461.17 1311.03 0.00 0.00 3.76 13.39 18.41 Receivable days 220.07 180.60 166.70 146.76 146.96 0.00 0.00 34.59 435.99 737.95 Inventory Days 5.05 0.00 1.78 6.66 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 73.37 76.85 67.89 50.00 34.94 101.81 23.21 0.00 688.54 0.00 Cash Conversion Cycle 151.74 103.75 100.59 103.42 112.02 -101.81 -23.21 34.59 -252.55 737.95 Total Debt/Equity 0.13 0.03 0.08 0.00 0.00 0.00 0.00 0.06 0.00 0.23 Interest Cover 45.29 203.45 140.54 196.86 1061.57 0.00 -3.23 -1.48 11.74 15.82

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 169.51 113.16 64.98 27.75 11.58 ROA 22.09% 34.52% 56.23% 29.01% 32.19% ROE 32.17% 53.50% 82.26% 39.04% 55.84% ROCE 37.46% 59.62% 92.56% 56.56% 69.35% Fixed Asset Turnover 9.18 17.32 157.71 461.40 1203.13 Receivable days 43.31 68.14 84.00 140.73 146.96 Inventory Days 110.51 73.37 11.40 6.66 0.00 Payable days 75.41 69.04 31.52 38.51 66.84 Cash Conversion Cycle 78.42 72.47 63.88 108.88 80.12 Total Debt/Equity 0.07 0.03 0.06 0.00 0.00 Interest Cover 42.33 72.69 160.34 184.97 1061.57

Top Investors:

elara india opportunities fund limited

mgc fund limited

rajasthan global securities private limited

amol anand mantri

mr. kunal bhakta

investor education and protection fund (iepf)

Annual Reports:

News Update:

Balaxi Pharmaceuticals’ arm incorporates new wholly owned subsidiary
14th Feb 2024, 17:40 PM

Consequent to the incorporation, Balaxi Pharmaceuticals Chile SPA has become a Wholly Owned Step-Down Subsidiary of the Company
Read More
Balaxi Pharma. - Quarterly Results
9th Feb 2024, 12:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback